TANG Capital Partners L.P., Chief Operating Officer, Officer, Chief Executive Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 73,700 shares at $12.03 ($956K) on 2018-12-27, disclosed to the SEC on 2018-12-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 10,000 | $120K | 12.6% |
| 2 | $12.04 | 10,000 | $120K | 12.6% |
| 3 | $12.04 | 10,000 | $120K | 12.6% |
| 4 | $13.35 | 10,000 | $134K | 14.0% |
| 5 | $13.42 | 10,000 | $134K | 14.0% |
| 6 | $13.51 | 10,000 |
| $135K |
| 14.1% |
| 7 | $13.99 | 10,000 | $140K | 14.6% |
| 8 | $14.00 | 3,700 | $52K | 5.4% |
| Total | $12.97 avg | 73,700 | $956K | 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |